A Surrey man with terminal brain cancer has been enrolled on a new medical treatment trial. Max Vardy, from Farnham, was ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.

研究首次构建了以IFI16为核心的“细胞衰老-铁死亡逃逸”的分子调控网络，并针对性的发现了新型胶质瘤辐射增敏药物，为胶质瘤辐射抵抗形成机制提供了全新理论框架，有望成为基础研究向临床转化的重要桥梁。

The University of Southern California (USC) has received a $6m grant from the California Institute for Regenerative Medicine ...

The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first ...

Concomitant radiotherapy plus temozolomide significantly increased progression-free survival versus radiotherapy alone in IDH ...

Katherine Webster was told she had months to live when she was diagnosed with a grade four glioblastoma in March 2020, aged ...

Glioblastoma Multiforme Treatment Market size is expected to reach USD 4.7 Billion by 2033 from USD 2.2 Billion in 2023, at a CAGR of 8.1%. Lawrence John Prudour +91 91308 55334 ...

Imvax is targeting the same form of brain cancer that claimed the lives of former Phillies pitcher Tug McGraw and catcher ...

The trial comes as a new study highlighted differences in how genes are activated in brain tumour cells compared to healthy ones.

Maxim initiated coverage of Kazia Therapeutics (KZIA) with a Buy rating and $3 price target The company’s lead asset is paxalisib, a potent, ...